Search hospitals > California > Anaheim

Advanced Research Center Inc.

Claim this profile
Anaheim, California 92805
Global Leader in Depression
Global Leader in Schizophrenia
Conducts research for Alzheimer's Disease
Conducts research for Major Depressive Disorder
Conducts research for Constipation
125 reported clinical trials
6 medical researchers
Photo of Advanced Research Center Inc. in AnaheimPhoto of Advanced Research Center Inc. in Anaheim

Summary

Advanced Research Center Inc. is a medical facility located in Anaheim, California. This center is recognized for care of Depression, Schizophrenia, Alzheimer's Disease, Major Depressive Disorder, Constipation and other specialties. Advanced Research Center Inc. is involved with conducting 125 clinical trials across 71 conditions. There are 6 research doctors associated with this hospital, such as Daniel Johnson, MD, Austina Cho, MD, Rennan Quijano, MD, and Johnson.

Top PIs

Clinical Trials running at Advanced Research Center Inc.

Alzheimer's Disease
Depression
Migraine
Dementia
Constipation
COVID-19
Coronavirus
Attention Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder
Schizophrenia
Image of trial facility.

AVP-786

for Agitation in Alzheimer's Disease

This study is evaluating whether a drug may help reduce the risk of heart attack and stroke in individuals with heart disease.
Recruiting2 awards Phase 37 criteria
Image of trial facility.

Masupirdine

for Agitation in Alzheimer's Disease

This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Recruiting1 award Phase 32 criteria
Image of trial facility.

ABBV-916

for Early Alzheimer's Disease

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or events, and may progress to noticeable memory loss, increased confusion and agitation, and eventually, loss of independence and non-responsiveness. This study will assess how safe and effective ABBV-916 is in treating early AD. Adverse events, change in disease activity, and how ABBV-916 moves through body of participants will be assessed. ABBV-916 is an investigational drug being developed for the treatment of early AD. This study is conducted in 2 stages. Stage A is a multiple ascending dose study. There is a 1 in 4 chance that participants are assigned to receive placebo. Stage B is a proof-of-concept study. In Stage B, there is a 1 in 5 chance that participants will be assigned to receive placebo. The first 6 months of this study are "double-blind," which means that neither the trial participant nor the study doctors know which treatments will be given. This will be followed by a 2-year extension period in which all participants will receive ABBV-916. Approximately 195 participants aged 50-90 years will be enrolled in about 90 sites across the world. Participants will receive intravenous (IV) doses of ABBV-916 or placebo once every 4 weeks (Q4W) for 24 weeks and will be followed for an additional 16 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, magnetic resonance imaging (MRI), blood tests, checking for side effects and completing questionnaires.
Recruiting0 awards Phase 26 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Advanced Research Center Inc.?
Advanced Research Center Inc. is a medical facility located in Anaheim, California. This center is recognized for care of Depression, Schizophrenia, Alzheimer's Disease, Major Depressive Disorder, Constipation and other specialties. Advanced Research Center Inc. is involved with conducting 125 clinical trials across 71 conditions. There are 6 research doctors associated with this hospital, such as Daniel Johnson, MD, Austina Cho, MD, Rennan Quijano, MD, and Johnson.